48
Participants
Start Date
December 31, 1998
Primary Completion Date
September 30, 2003
Study Completion Date
September 30, 2003
alvocidib
carboplatin
cisplatin
Mayo Clinic, Rochester
Lead Sponsor
National Cancer Institute (NCI)
NIH
Mayo Clinic
OTHER